Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors
- 1 January 2007
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 73 (2) , 259-269
- https://doi.org/10.1016/j.bcp.2006.09.030
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Successful Virtual Screening for a Submicromolar Antagonist of the Neurokinin-1 Receptor Based on a Ligand-Supported Homology ModelJournal of Medicinal Chemistry, 2004
- Potential therapeutic targets for neurokinin-1 receptor antagonistsEmerging Drugs, 2004
- Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclatureTrends in Pharmacological Sciences, 2004
- Pharmacological Profile of (2 R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor AntagonistThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Derivation of a Three-Dimensional Pharmacophore Model of Substance P Antagonists Bound to the Neurokinin-1 ReceptorJournal of Medicinal Chemistry, 1998
- A Structural Rationale for the Design of Water Soluble Peptide-Derived Neurokinin-1 AntagonistsJournal of Receptors and Signal Transduction, 1997
- Interaction of Substance P with the Second and Seventh Transmembrane Domains of the Neurokinin-1 ReceptorBiochemistry, 1994
- Tachykinin receptors and tachykinin receptor antagonistsJournal of Autonomic Pharmacology, 1993
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973